title: Tryptophan depletion in SSRI-recovered depressed outpatients.
abstract: BACKGROUND
  Recently, a number of studies have challenged the finding that acute tryptophan depletion (TD) increases depressive symptoms in medicated, formerly depressed patients. The present study examined the effects of acute nutritional TD on remitted depressed patients currently treated with selective serotonin reuptake inhibitors. In an attempt to clarify conflicting earlier findings, the effects of a number of clinical variables on outcome were also investigated.
  
  
  METHODS
  Ten patients underwent TD in a double-blind, controlled, balanced crossover fashion. The control session followed the procedure of Krahn et al. (1996 Neuropsychopharmacology 15:325-328). Sessions were 5-8 days apart.
  
  
  RESULTS
  TD was significantly related to increased scores on clinician-rated depression and anxiety scales, and on self-rated depression, anxiety, and somatic symptoms. The control challenge had no effect, despite the fact that the reductions in plasma tryptophan during the control session were unexpectedly high. Some evidence was found for a threshold in the relationship between reduction of plasma tryptophan and mood response.
  
  
  CONCLUSIONS
  The mood effect of TD in medicated, formerly depressed patients was confirmed. A threshold may exist for mood effects following TD, implying that recent negative findings may have been caused by insufficient depletion. No other predicting or mediating factors were identified, although the variable "history of response pattern to medication" deserves further study.
authors.affiliation: Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA 02114, USA.
authors.forename: M K
authors.initials: MK
authors.lastname: Spillmann
authors.forename: A J
authors.initials: AJ
authors.lastname: Van der Does
authors.forename: M A
authors.initials: MA
authors.lastname: Rankin
authors.forename: R D
authors.initials: RD
authors.lastname: Vuolo
authors.forename: J E
authors.initials: JE
authors.lastname: Alpert
authors.forename: A A
authors.initials: AA
authors.lastname: Nierenberg
authors.forename: J F
authors.initials: JF
authors.lastname: Rosenbaum
authors.forename: D
authors.initials: D
authors.lastname: Hayden
authors.forename: D
authors.initials: D
authors.lastname: Schoenfeld
authors.forename: M
authors.initials: M
authors.lastname: Fava
mesh_terms: D000293:Adolescent; D000328:Adult; D000339:Affect / Q000187:drug effects; D000368:Aged; D000596:Amino Acids / Q000378:metabolism; D001519:Behavior / Q000187:drug effects; D003866:Depressive Disorder / Q000188:drug therapy / Q000378:metabolism / Q000523:psychology*; D004032:Diet; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D014364:Tryptophan / Q000097:blood / Q000172:deficiency*
chemical_list: D000596:Amino Acids; D017367:Selective Serotonin Reuptake Inhibitors; D014364:Tryptophan